Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review

por Bteich, Fernand, Mohammadi, Mahshid, Li, Terence, Bhat, Muzaffer Ahmed, Sofianidi, Amalia, Wei, Ning, Kuang, Chaoyuan
Publicado 2023

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

por Kuang, Chaoyuan, Quann, Kevin, Liman, Agnes K., Frye, Roy, Alshoubaki, Nawras, Ramkumar, Mohan, Liman, Andrew D.
Publicado 2020

Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer

por Song, Xiangping, Shen, Lin, Tong, Jingshan, Kuang, Chaoyuan, Zeng, Shan, Schoen, Robert E., Yu, Jian, Pei, Haiping, Zhang, Lin
Publicado 2020

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death

por Kuang, Chaoyuan, Tong, Jingshan, Ermine, Kaylee, Cai, Manbo, Dai, Fujun, Hao, Suisui, Giles, Francis, Huang, Yi, Yu, Jian, Zhang, Lin
Publicado 2022

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

por Kuang, Chaoyuan, Park, Yongseok, Augustin, Ryan C., Lin, Yan, Hartman, Douglas J., Seigh, Lindsey, Pai, Reetesh K., Sun, Weijing, Bahary, Nathan, Ohr, James, Rhee, John C., Marks, Stanley M., Beasley, H. Scott, Shuai, Yongli, Herman, James G., Zarour, Hassane M., Chu, Edward, Lee, James J., Krishnamurthy, Anuradha
Publicado 2022